(Q36901974)

17 August 2017

1 reference

title

An update on the management of Chagas cardiomyopathy (English)

1 reference

17 August 2017

0 references

2

Mauro M Teixeira

1 reference

17 August 2017

Manoel O C Rocha

1

1 reference

17 August 2017

Antonio L Ribeiro

series ordinal

3

1 reference

17 August 2017

publication date

1 August 2007

1 reference

Expert Review of Anti-infective Therapy

17 August 2017

published in

1 reference

17 August 2017

volume

5

1 reference

17 August 2017

issue

4

1 reference

17 August 2017

page(s)

727-743

1 reference

Clinical management of chronic Chagas cardiomyopathy

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.727

[Notes about of Trypanosoma cruzi and yours bio-ecology characteristics with agents of the transmission by meals].

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.727

Laboratory-acquired parasitic infections from accidental exposures

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.727

The future of Chagas disease control

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.727

Control of Chagas disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.727

Chagas disease: successes and challenges.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.727

Ageing with Trypanosoma cruzi infection in a community where the transmission has been interrupted: the Bambuí Health and Ageing Study (BHAS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.727

Measures to prevent transfusion-associated protozoal infections in non-endemic countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.727

Reactivation of Chagas' disease in patients with AIDS: report of three new cases and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.727

Clinical and epidemiological aspects of Chagas disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.727

Active orthostatic stress and respiratory sinus arrhythmia in patients with Chagas' disease with preserved left ventricular global systolic function

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.727

Pathogenesis of chronic Chagas heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.727

Parasite persistence in the aetiology of Chagas disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.727

Chagas' heart disease: clinical-pathological correlation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.727

Predictors of mortality in chronic Chagas disease: a systematic review of observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.727

Prognostic value of QT interval parameters for mortality risk stratification in Chagas' disease: results of a long-term follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.727

Clinical predictors of chronic chagasic myocarditis progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.727

Clinical usefulness of electrophysiologic testing in patients with ventricular tachycardia and chronic chagasic cardiomyopathy treated with amiodarone or sotalol

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.727

Predictive value of clinical and electrophysiological variables in patients with chronic chagasic cardiomyopathy and nonsustained ventricular tachycardia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.727

Development and validation of a risk score for predicting death in Chagas' heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.727

Clinical characteristics of acute myocardial infarction in patients with Chagas' disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.727

Detection of early right ventricular dysfunction in Chagas' disease using Doppler tissue imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.727

Morphofunctional characteristics of the right ventricle in Chagas' dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.727

Sudden cardiac death in patients with chagas heart disease and preserved left ventricular function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.727

Peculiar aspects of cardiogenic embolism in patients with Chagas' cardiomyopathy: a transthoracic and transesophageal echocardiographic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.727

Chagasic cardiomyopathy is independently associated with ischemic stroke in Chagas disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.727

American trypanosomiasis (Chagas' disease): an unrecognised cause of stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.727

Noninvasive prognostic markers for cardiac death and ventricular arrhythmia in long-term follow-up of subjects with chronic Chagas' disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.727

ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the [...]

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.727

Tissue Doppler imaging enables the identification of diastolic dysfunction of pseudonormal pattern in Chagas' disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.727

N-terminal proBNP levels in patients with Chagas disease: a marker of systolic and diastolic dysfunction of the left ventricle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.727

Brain natriuretic peptide and left ventricular dysfunction in Chagas' disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.727

Brain natriuretic peptide in Chagas' disease: further insights

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.727

Brain natriuretic peptide based strategy to detect left ventricular dysfunction in Chagas disease: a comparison with the conventional approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.727

Brain natriuretic peptide measurement in Chagas heart disease: marker of ventricular dysfunction and arrhythmia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.727

Holter monitoring in Chagas' heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.727

Clinical and electrophysiologic features of syncope in chronic chagasic heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.727

Heart rate variability and its sympatho-vagal modulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.727

Power-law behavior of heart rate variability in Chagas' disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.727

Heart rate turbulence and left ventricular ejection fraction in Chagas disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.727

Ventricular tachycardia during exercise testing as a predictor of sudden death in patients with chronic chagasic cardiomyopathy and ventricular arrhythmias

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.727

Chronotropic incompetence and abnormal autonomic modulation in ambulatory Chagas disease patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.727

Cardiac magnetic resonance in Chagas' disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.727

Chemotherapy of Chagas disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.727

Toxic side effects of drugs used to treat Chagas' disease (American trypanosomiasis)

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.727

Chagas' disease: carcinogenic activity of the antitrypanosomal nitroarenes in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.727

Risk stratification in a Brazilian hospital-based cohort of 1220 outpatients with heart failure: role of Chagas' heart disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.727

A randomized trial of carvedilol after renin-angiotensin system inhibition in chronic Chagas cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.727

Effects of metoprolol in chagasic patients with severe congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.727

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.727

CHARITY: Chagas cardiomyopathy bisoprolol intervention study: a randomized double-blind placebo force-titration controlled study with Bisoprolol in patients with chronic heart failure secondary to Chagas cardiomyopathy [NCT00323973].

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.727

Chagas' disease and the use of implantable cardioverter-defibrillators in Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.727

Cell transplantation after the coculture of skeletal myoblasts and mesenchymal stem cells in the regeneration of the myocardium scar: an experimental study in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.727

Simultaneous autologous transplantation of cocultured mesenchymal stem cells and skeletal myoblasts improves ventricular function in a murine model of Chagas disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.727

Transplanted bone marrow cells repair heart tissue and reduce myocarditis in chronic chagasic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.727

Bone marrow cell transplantation to the myocardium of a patient with heart failure due to Chagas' disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.727

Anti-beta1-adrenergic receptor autoantibodies in patients with chronic Chagas heart disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.727

Automatic implantable cardioverter-defibrillators in Chagas' heart disease patients with malignant ventricular arrhythmias.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.727

Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.727

New perspectives on catheter-based ablation of ventricular tachycardia complicating Chagas' disease: experimental evidence of the efficacy of near infrared lasers for catheter ablation of Chagas' VT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.727

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.727

Antithrombotic and thrombolytic therapy: from evidence to application: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.727

The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.727

Manifestations of Chagas disease (American trypanosomiasis) in patients with HIV/AIDS

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.727

Parasympathetic dysautonomia precedes left ventricular systolic dysfunction in Chagas disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.727

A Risk Score for Predicting Death in Chagas' Heart Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.727

Diastolic function in Chagas' disease: an echo and tissue Doppler imaging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.727

Tissue Doppler imaging in the evaluation of the regional diastolic function in chagas' disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.727

Vagal dysfunction in Chagas disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.4.727

21 January 2018

Identifiers

DOI

10.1586/14787210.5.4.727

1 reference

17 August 2017

1 reference